Clinical trial
A Prospective Multicenter Randomized Trial to Assess the Safety and Effectiveness of EXCEL-II vs. EXCEL Sirolimus Eluting Stent for the Treatment of Patients With de Novo Coronary Artery Lesions .( CREDIT II Trial )
NCT02057978 is registered in ClinicalTrials.gov with JW Medical Systems Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Randomized Trial to Assess the Safety and Effectiveness of EXCEL-II vs. EXCEL Sirolimus Eluting Stent for the Treatment of Patients With de Novo Coronary Artery Lesions .( CREDIT II Trial )
- Lead sponsor
- JW Medical Systems Ltd
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 8, 2013
- Completion date
- December 25, 2019
- Enrollment
- 419 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.